Robert Peter Kadlec - Oct 30, 2024 Form 3 Insider Report for MiNK Therapeutics, Inc. (INKT)

Role
Director
Signature
Christine M. Klaskin, by Power of Attorney
Stock symbol
INKT
Transactions as of
Oct 30, 2024
Transactions value $
$0
Form type
3
Date filed
12/9/2024, 04:05 PM

No securities are beneficially owned.